4.7 Article

Long-term efficacy of canakinumab in the treatment of Schnitzler syndrome

Journal

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 145, Issue 6, Pages 1681-+

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2019.12.909

Keywords

-

Funding

  1. Novartis Pharma GmbH

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available